COVID-19 patients with hypoxia appear to be suffering from prothrombotic conditions, through the upregulation of PAI-1 and the stimulation of procoagulants synthesis, like TF and von Willebrand Factor (vWF) [34]. This evidence concerns the gene SERPINE1 and COVID-19.